Mixed acinar-neuroendocrine tumor of the pancreas
Conditions
Interventions
Observation group:N/A
Sponsors
The Fifth Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.The pathological and immunohistochemical results of preoperative and / or intraoperative samples suggested mixed acinar neuroendocrine tumors of the pancreas, and the proportion of acinar cell differentiation components to neuroendocrine differentiation components was = 30%; 2.Irreversible electroporation (IRE) was performed during the diagnosis and treatment process, and subsequent surgery, chemoradiotherapy and systemic treatment plan adjustment were accepted under the comprehensive management of the multidisciplinary team (MDT) (subject to the actual treatment record); 3.The medical records, images and follow-up records are relatively complete and traceable, and can retrospectively present the longitudinal changes of diagnosis treatment follow-up outcomes;
Exclusion criteria
Exclusion criteria: 1.The pathological evidence was insufficient to definitively diagnose pancreatic mixed acinar neuroendocrine tumor; 2.Key clinical data are missing and cannot be completed (such as main treatment process, core imaging / pathological results or follow-up results, etc.); 3.The data cannot be effectively de identified, and there is a high individual identifiable risk;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IRE Feasibility/Technical Completion Status;Critical vital signs abnormal events and management; | — |
Secondary
| Measure | Time frame |
|---|---|
| Survival time of patients with pancreatic mixed acinar neuroendocrine tumors treated with irreversible electroporation; | — |
Countries
China
Contacts
Public ContactChen Yanjun
The Fifth Affiliated Hospital of Zhengzhou University
Outcome results
None listed